Study | Difference in mean costs (€) | Difference in mean effectiveness | Ceiling cost-effectiveness ratio | Standard deviation of costs (€) | Standard deviation of effectiveness | Coefficient of correlation between the difference in costs and the difference in effectiveness | Sample size per group through the method proposed by Glick a |
---|---|---|---|---|---|---|---|
(∆C) | (∆E) | (λ) | (σC) | (σE) | (ρ) | ||
FEMCAT | 312 | 0,07 | 16,750 € /complication avoided | 100 | 0,41 | 0 | 1000 |
INTACT | − 725 | 0,075 | 20,000 € /QALY | 800 | 0,24 | 0 | 75 |
OXYNAT | 17,6 | 0,00048 | 100,000 € /complication avoided | 1008 | 0,00078 | 0 | 17,350 |